© Copyright 2025 American Medical Association. All rights reserved.
The procedure described by CPT® Code 0814T involves the percutaneous injection of a calcium-based biodegradable osteoconductive material into the proximal femur. This technique is primarily aimed at reinforcing the structural integrity of the proximal femur, which is particularly beneficial in preventing hip fractures, especially among elderly patients who may be susceptible to such injuries due to low-impact trauma. The procedure is often indicated for patients who have already sustained a hip fracture, as it can provide additional support to the affected area. In some cases, the injection may also be performed on the contralateral side during the surgical intervention for the fracture, thereby strengthening the other hip to mitigate the risk of future fractures. The process begins with a small incision to access the femoral cortex, followed by the insertion of a tissue protector and an obturator. A guide pin is then advanced to the apex of the femoral neck, facilitating the subsequent steps of drilling and injection. The use of imaging guidance, specifically fluoroscopy, ensures accurate placement of the osteoconductive material, which is injected in a continuous manner until it reaches the lateral cortex. This procedure is time-sensitive, requiring the injection to be completed within five minutes of mixing the material, and concludes with a thorough check for any leakage at the injection site before the instruments are removed.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure is indicated for the following conditions:
The procedure consists of several detailed steps to ensure the effective injection of the calcium-based biodegradable osteoconductive material into the proximal femur:
Post-procedure care involves monitoring the injection site for any signs of leakage or complications. Patients may be advised on activity restrictions to ensure proper healing and to avoid undue stress on the proximal femur. Follow-up imaging may be necessary to assess the effectiveness of the injection and the integrity of the femur. Additionally, healthcare providers should provide instructions on pain management and any other supportive care needed during the recovery period.
Short Descr | PRQ NJX BIOD OSTEO MATRL FEM | Medium Descr | PERQ NJX CALCIUM BIOD OSTEOCONDUCTIVE MATRL FEM | Long Descr | Percutaneous injection of calcium-based biodegradable osteoconductive material, proximal femur, including imaging guidance, unilateral | Status Code | Carriers Price the Code | Global Days | YYY - Carrier Determines Whether Global Concept Applies | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 1 - 150% payment adjustment for bilateral procedures applies. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
Date
|
Action
|
Notes
|
---|---|---|
2024-01-01 | Added | Code Added. |
Get instant expert-level medical coding assistance.